The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs-Reference-Cited by-同舟云学术

The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs

Published:2016-06 Issue:6 Volume:11 Page:862-872
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Micke Patrick,Mattsson Johanna Sofia Margareta,Djureinovic Dijana,Nodin Björn,Jirström Karin,Tran Lena,Jönsson Per,Planck Maria,Botling Johan,Brunnström Hans

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference43 articles.

1. Intricacies of bevacizumab-induced toxicities and their management;Gressett;Ann Pharmacother,2009

2. Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer;Scagliotti;J Thorac Oncol,2011

3. Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline

4. Benefit-risk summary of nivolumab for patients with metastatic squamous cell lung cancer after platinum-based chemotherapy: a report from the US Food and Drug Administration;Kazandjian;JAMA Oncol,2016

5. Patients with non-small cell lung cancer analyzed for EGFR: adherence to guidelines, prevalence and outcome;Sandelin;Anticancer Res,2015

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined treatment with cetuximab and STA9090 has synergistic anticancer effects on human non-small cell lung cancer;Acta Biochimica et Biophysica Sinica;2024-05-30

2. Pseudosquamous Adenocarcinoma of the Lung;American Journal of Surgical Pathology;2024-05-20

3. Systemic immune-inflammation index predicts survival in patients with resected lung invasive mucinous adenocarcinoma;Translational Oncology;2024-02

4. Exploring fucosylation in lung cancer: Mechanisms, diagnosis, and therapeutic strategies;Advances in Biomarker Sciences and Technology;2024

5. Pulmonary squamous cell carcinoma and lymphoepithelial carcinoma – morphology, molecular characteristics and differential diagnosis;Histopathology;2023-11-07